CN102229944B - 一种重组猪α-干扰素的制备方法 - Google Patents
一种重组猪α-干扰素的制备方法 Download PDFInfo
- Publication number
- CN102229944B CN102229944B CN 201110148880 CN201110148880A CN102229944B CN 102229944 B CN102229944 B CN 102229944B CN 201110148880 CN201110148880 CN 201110148880 CN 201110148880 A CN201110148880 A CN 201110148880A CN 102229944 B CN102229944 B CN 102229944B
- Authority
- CN
- China
- Prior art keywords
- primer
- interferon
- alpha
- pcr
- carrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract description 10
- 108010047761 Interferon-alpha Proteins 0.000 claims abstract description 29
- 230000014509 gene expression Effects 0.000 claims abstract description 24
- 241000235058 Komagataella pastoris Species 0.000 claims abstract description 18
- 102000006992 Interferon-alpha Human genes 0.000 claims abstract description 13
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 238000012216 screening Methods 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- 239000007788 liquid Substances 0.000 claims description 24
- 235000015097 nutrients Nutrition 0.000 claims description 24
- 241000235648 Pichia Species 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 22
- 108090000623 proteins and genes Proteins 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 17
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 230000005611 electricity Effects 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 5
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 238000013467 fragmentation Methods 0.000 claims description 4
- 238000006062 fragmentation reaction Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 3
- 230000029087 digestion Effects 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- 108700005078 Synthetic Genes Proteins 0.000 claims description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 2
- 238000000137 annealing Methods 0.000 claims description 2
- 230000004087 circulation Effects 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 2
- 238000013461 design Methods 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 238000011156 evaluation Methods 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 6
- 230000003248 secreting effect Effects 0.000 abstract description 6
- 230000000840 anti-viral effect Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 2
- 108091026890 Coding region Proteins 0.000 abstract 2
- 238000003752 polymerase chain reaction Methods 0.000 abstract 2
- 238000010367 cloning Methods 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 description 18
- 108010050904 Interferons Proteins 0.000 description 18
- 229940079322 interferon Drugs 0.000 description 18
- 239000002609 medium Substances 0.000 description 18
- 241000282898 Sus scrofa Species 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 13
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 241000700605 Viruses Species 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 230000006698 induction Effects 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005070 sampling Methods 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 241000711975 Vesicular stomatitis virus Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 230000010748 Photoabsorption Effects 0.000 description 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 231100000645 Reed–Muench method Toxicity 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 101150099105 alien gene Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000012807 shake-flask culturing Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000012153 swine disease Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 208000005925 vesicular stomatitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110148880 CN102229944B (zh) | 2011-06-03 | 2011-06-03 | 一种重组猪α-干扰素的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110148880 CN102229944B (zh) | 2011-06-03 | 2011-06-03 | 一种重组猪α-干扰素的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102229944A CN102229944A (zh) | 2011-11-02 |
CN102229944B true CN102229944B (zh) | 2013-02-06 |
Family
ID=44842549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110148880 Active CN102229944B (zh) | 2011-06-03 | 2011-06-03 | 一种重组猪α-干扰素的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102229944B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102229667A (zh) * | 2011-06-03 | 2011-11-02 | 北京伟嘉人生物技术有限公司 | 一种聚乙二醇修饰的猪α-干扰素及其制备方法和应用 |
CN110343164A (zh) * | 2019-08-22 | 2019-10-18 | 安阳工学院 | 一种高活性7位点突变的猪干扰素α突变体及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322110C (zh) * | 2005-04-19 | 2007-06-20 | 湖北大学 | 一种酵母基因工程菌及耐热耐碱木聚糖酶制剂和应用方法 |
CN101157724A (zh) * | 2007-11-06 | 2008-04-09 | 中国科学院微生物研究所 | 一种改良重组猪α干扰素蛋白及其编码基因与应用 |
CN101450961A (zh) * | 2007-11-28 | 2009-06-10 | 成都乾盛昌生物科技有限公司 | 人工合成的猪干扰素基因及制备猪干扰素的方法 |
CN101818154A (zh) * | 2010-03-26 | 2010-09-01 | 华南农业大学 | 编码猪α、β或γ干扰素的基因片段及其应用 |
CN101845441A (zh) * | 2010-03-16 | 2010-09-29 | 南京农业大学 | 一种复合猪α干扰素基因及其重组载体 |
-
2011
- 2011-06-03 CN CN 201110148880 patent/CN102229944B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1322110C (zh) * | 2005-04-19 | 2007-06-20 | 湖北大学 | 一种酵母基因工程菌及耐热耐碱木聚糖酶制剂和应用方法 |
CN101157724A (zh) * | 2007-11-06 | 2008-04-09 | 中国科学院微生物研究所 | 一种改良重组猪α干扰素蛋白及其编码基因与应用 |
CN101450961A (zh) * | 2007-11-28 | 2009-06-10 | 成都乾盛昌生物科技有限公司 | 人工合成的猪干扰素基因及制备猪干扰素的方法 |
CN101845441A (zh) * | 2010-03-16 | 2010-09-29 | 南京农业大学 | 一种复合猪α干扰素基因及其重组载体 |
CN101818154A (zh) * | 2010-03-26 | 2010-09-01 | 华南农业大学 | 编码猪α、β或γ干扰素的基因片段及其应用 |
Non-Patent Citations (4)
Title |
---|
姚清侠 等.猪α-干扰素在毕赤酵母中的分泌表达及其生物活性测定.《中国兽医学报》.2008,第28卷(第12期),第1456-1460页. * |
张存 等.猪α干扰素在毕赤酵母中的高效表达和纯化.《浙江农业学报》.2010,第22卷(第1期),第6-9页. * |
李鹏飞 等.猪干扰素α 基因的克隆与真核表达.《中国生物制品学杂志》.2010,第23卷(第4期),第369-372页. * |
林宝珍 等.猪IFN-α在巴斯德毕赤酵母中的分泌表达.《华南农业大学学报》.2010,第31卷(第1期),第122-124页. * |
Also Published As
Publication number | Publication date |
---|---|
CN102229944A (zh) | 2011-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105567598A (zh) | 一种藏猪源解淀粉芽孢杆菌及其应用 | |
CN101985605B (zh) | 一种水霉拮抗菌及其应用 | |
CN101289666B (zh) | 重组猪α型干扰素的制备方法 | |
CN101736062A (zh) | 一种重组猪α干扰素标准品的制备方法 | |
CN107412762A (zh) | 一种新城疫、禽流感、法氏囊和禽腺病毒四联疫苗 | |
CN102229944B (zh) | 一种重组猪α-干扰素的制备方法 | |
CN103981192A (zh) | 表达山羊α干扰素的重组腺病毒及其构建方法和应用 | |
CN103450355A (zh) | 重组牛alpha干扰素及其应用 | |
CN102268410B (zh) | 一株适应幼仓鼠肾传代细胞的新城疫病毒耐热弱毒株及其制备方法和应用 | |
CN104328129A (zh) | 柔嫩艾美耳球虫保守蛋白Et CHP39基因及其应用 | |
CN106367422A (zh) | 一种重组羊干扰素τ生物学活性检测用标准品的制备方法 | |
CN104513302B (zh) | 获自埃及伊蚊的防御素及其编码基因和应用 | |
CN102199215B (zh) | Mapwa融合抗菌肽及其制备方法与应用 | |
CN102899331B (zh) | 一种复合鸭α干扰素基因、其重组载体及应用 | |
CN108948163A (zh) | 澳洲坚果植物防御素及其应用 | |
CN101845441B (zh) | 一种复合猪α干扰素基因及其重组载体 | |
CN104498417A (zh) | 猪链球菌分支酸合酶基因缺失株、其构建方法及应用 | |
CN103012578A (zh) | 一种重组猪白细胞介素2及其编码基因和表达方法 | |
CN103319590B (zh) | 栉孔扇贝肽聚糖识别蛋白(CfPGRP-S1)的应用 | |
CN113512559A (zh) | 牛支原体Mbov_0701突变基因及其突变株和应用 | |
CN102010867A (zh) | 重组中华蜜蜂王浆主蛋白AccMRJP1的酵母表达方法及产物用途 | |
CN103014015A (zh) | 编码猪γ干扰素的基因片段及其应用 | |
CN101531967A (zh) | 一种生产α干扰素的方法及其专用菌 | |
CN110343164A (zh) | 一种高活性7位点突变的猪干扰素α突变体及其制备方法和应用 | |
CN108129570A (zh) | 融合牛抗菌肽与白细胞介素2共表达重组酵母菌制剂的制备及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING HEI JIN GANG AGRICULTURE CO.,LTD. Effective date: 20150112 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150112 Address after: 100085 Jiahua building, D803 information industry base, Haidian District, Beijing, Zhongguancun Patentee after: Beijing Vicaren Biological Technology Co., Ltd. Address before: 100085 Jiahua building, D803 information industry base, Haidian District, Beijing, Zhongguancun Patentee before: Beijing Vicaren Biological Technology Co., Ltd. Patentee before: Beijing Heijingang Agricultural Ltd. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 100085 Jiahua building, D803 information industry base, Haidian District, Beijing, Zhongguancun Patentee after: Beijing WIK biotechnology Limited by Share Ltd Address before: 100085 Jiahua building, D803 information industry base, Haidian District, Beijing, Zhongguancun Patentee before: Beijing Vicaren Biological Technology Co., Ltd. |
|
TR01 | Transfer of patent right |
Effective date of registration: 20210423 Address after: 410331 No.321, Kangning Road, Liuyang economic and Technological Development Zone, Changsha City, Hunan Province Patentee after: HUNAN CANZOHO BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 100085 Jiahua building, D803 information industry base, Haidian District, Beijing, Zhongguancun Patentee before: BEIJING VICA BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |